161 related articles for article (PubMed ID: 3798417)
21. Cross-reactivity of the anti-human D-dimer monoclonal antibody 1C9-6F10 to canine fibrin degradation products.
Miura N; Furukawa M; Magari Y; Momoi Y
J Vet Med Sci; 2013 Jul; 75(7):963-6. PubMed ID: 23420644
[TBL] [Abstract][Full Text] [Related]
22. [FDP-E--quantitative analysis by LPIA (latex photometric immunoassay) method].
Furusaki F; Sudo T; Tsutsui S
Rinsho Byori; 1989 Apr; Spec No 81():168-75. PubMed ID: 2754804
[No Abstract] [Full Text] [Related]
23. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; FDP D dimer analysis using NANOPIA FDP].
Matsumoto T; Sakai Y; Maeda M; Takei F
Rinsho Byori; 1989 Apr; Spec No 81():183-8. PubMed ID: 2754806
[No Abstract] [Full Text] [Related]
24. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T
Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066
[TBL] [Abstract][Full Text] [Related]
25. New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies.
Nieuwenhuizen W
Blut; 1988 Nov; 57(5):285-91. PubMed ID: 3058234
[TBL] [Abstract][Full Text] [Related]
26. Determination of FDP in human plasma by a novel latex immunoassay.
Sakai Y; Maeda M; Takei F; Matsumoto T; Nishijima Y; Nakamura K
Thromb Res; 1988 May; 50(4):469-79. PubMed ID: 3413715
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody-based plasma assays for fibrin(ogen) and derivatives, and their clinical relevance.
Kroneman H; Nieuwenhuizen W; Knot EA
Blood Coagul Fibrinolysis; 1990; 1(1):91-111. PubMed ID: 2102791
[TBL] [Abstract][Full Text] [Related]
28. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
Koppert PW; Kuipers W; Hoegee-de Nobel B; Brommer EJ; Koopman J; Nieuwenhuizen W
Thromb Haemost; 1987 Feb; 57(1):25-8. PubMed ID: 2438796
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a new anti-fibrinogen-coated latex particle agglutination test in the measurement of serum fibrin degradation products.
Marder VJ; Cruz GO; Schumer BR
Thromb Haemost; 1977 Apr; 37(2):183-91. PubMed ID: 577622
[TBL] [Abstract][Full Text] [Related]
30. [A new method for determination of DD/E complex using latex agglutination].
Soe G; Kohno I; Motojima M; Saito M; Matsuda M; Terukina S
Rinsho Byori; 1989 Apr; Spec No 81():176-82. PubMed ID: 2754805
[No Abstract] [Full Text] [Related]
31. Rapid quantitative evaluation of plasma D-dimer levels in thrombotic states using an automated latex photometric immunoassay.
Kario K; Matsuo T; Kabayashi H; Matsuo M; Yamamoto K; Sakurai G; Baba M
Thromb Res; 1992 May; 66(2-3):179-89. PubMed ID: 1412191
[TBL] [Abstract][Full Text] [Related]
32. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products.
Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J
Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388
[TBL] [Abstract][Full Text] [Related]
33. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
Lane DA; Preston FE; VanRoss ME; Kakkar VV
Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218
[TBL] [Abstract][Full Text] [Related]
34. [Fibrin/fibrinogen degradation products (FDP)].
Kuroso K; Fujimaki M
Nihon Rinsho; 1989 Dec; 48 Suppl():892-5. PubMed ID: 2622025
[No Abstract] [Full Text] [Related]
35. Latex immunoturbidimetric assay for soluble fibrin complex.
Hamano A; Umeda M; Ueno Y; Tanaka S; Mimuro J; Sakata Y
Clin Chem; 2005 Jan; 51(1):183-8. PubMed ID: 15514091
[TBL] [Abstract][Full Text] [Related]
36. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
Chen JP; Williams TK; Legendre AM
Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
[TBL] [Abstract][Full Text] [Related]
37. Fibrin D-dimer in thrombogenic disorders.
Matsuo T; Kobayashi H; Kario K; Suzuki S
Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of disseminated intravascular coagulation. Role of D-dimer.
Carr JM; McKinney M; McDonagh J
Am J Clin Pathol; 1989 Mar; 91(3):280-7. PubMed ID: 2646905
[TBL] [Abstract][Full Text] [Related]
39. False-negative test for fibrinogen--fibrin degradation products.
Kickler T; Bell WR
Am J Clin Pathol; 1977 Jul; 68(1):78-80. PubMed ID: 868807
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). I. Characterization and preliminary evaluation in plasma.
Gaffney PJ; Creighton LJ; Perry MJ; Callus M; Thorpe R; Spitz M
Br J Haematol; 1988 Jan; 68(1):83-90. PubMed ID: 3345297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
